KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Gross Profit (2016 - 2025)

Historic Gross Profit for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $205.3 million.

  • Medpace Holdings' Gross Profit rose 1514.1% to $205.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $760.6 million, marking a year-over-year increase of 1589.4%. This contributed to the annual value of $760.6 million for FY2025, which is 1589.4% up from last year.
  • As of Q4 2025, Medpace Holdings' Gross Profit stood at $205.3 million, which was up 1514.1% from $196.9 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Gross Profit peaked at $205.3 million during Q4 2025, and registered a low of $74.7 million during Q2 2021.
  • In the last 5 years, Medpace Holdings' Gross Profit had a median value of $131.7 million in 2023 and averaged $135.1 million.
  • As far as peak fluctuations go, Medpace Holdings' Gross Profit skyrocketed by 619.42% in 2021, and later surged by 3667.46% in 2022.
  • Medpace Holdings' Gross Profit (Quarter) stood at $88.0 million in 2021, then soared by 31.54% to $115.7 million in 2022, then rose by 18.21% to $136.8 million in 2023, then surged by 30.34% to $178.3 million in 2024, then grew by 15.14% to $205.3 million in 2025.
  • Its Gross Profit stands at $205.3 million for Q4 2025, versus $196.9 million for Q3 2025 and $180.0 million for Q2 2025.